Parris Kidd, Ph.D., earned his doctorate in cell biology-zoology from the University of California, Berkeley. Beginning in 1984, while a National Institutes of Health (NIH)-funded research investigator at the University of California San Francisco (UCSF) Medical Center, he published authoritative texts on antioxidants that launched him into nutritional medicine. In 1994, Kidd helped establish phosphatidylserine (PS), then glycerophosphocholine (GPC). His brain formulas have earned awards from the dietary supplement industry. Kidd is chief science officer and director of quality for BrainMD Health. He collaborates with the Amen Clinics to develop clinically validated products for memory, mood, behavior and healthy aging.
Latest from Parris Kidd
All from Parris Kidd
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023